levamisole has been researched along with choline in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atchison, WD; Geary, TG; Manning, B; Thompson, DP; VandeWaa, EA | 1 |
| Arevalo, JI; Saz, HJ | 1 |
| Arevalo, J; Saz, HJ | 1 |
| Mettrick, DF; Sangster, NC | 1 |
| Mathison, DA; O'Connor, R; Ring, J | 1 |
| Stul, MS; Uytterhoven, JB; Vliers, DP | 1 |
| Hwang, YH; Park, SP; Suh, CK | 1 |
| Evans, SP; Francis, MM; Jensen, M; Madsen, DM; Mancuso, J; Maricq, AV; Norman, KR | 1 |
8 other study(ies) available for levamisole and choline
| Article | Year |
|---|---|
Comparative neuromuscular blocking actions of levamisole and pyrantel-type anthelmintics on rat and gastrointestinal nematode somatic muscle.
Topics: Animals; Anthelmintics; Choline; Diaphragm; Female; Haemonchus; In Vitro Techniques; Levamisole; Male; Membrane Potentials; Muscle Contraction; Muscle, Smooth; Muscles; Nematoda; Neuromuscular Blocking Agents; Pyrantel; Rats; Rats, Inbred Strains; Sheep; Synaptic Transmission | 1992 |
Effects of cholinergic agents on the metabolism of choline in muscle from Ascaris suum.
Topics: Acetylcholine; Animals; Ascaris; Carbachol; Choline; Cytidine Diphosphate Choline; Female; Glycerylphosphorylcholine; Levamisole; Muscles; Phosphatidylcholines; Phosphorylcholine | 1992 |
Phospholipids and protein kinase C in acetylcholine-dependent signal transduction in Ascaris suum.
Topics: Acetylcholine; Animals; Ascaris; Carbachol; Choline; Female; Levamisole; Muscles; Phospholipases; Phospholipids; Protein Kinase C; Signal Transduction | 1991 |
Effects of cholinergic drugs on muscle contraction in Moniliformis moniliformis (Acanthocephala).
Topics: Acanthocephala; Acetylcholine; Acetylcholinesterase; Animals; Butyrylcholinesterase; Carbachol; Choline; Female; Helminthiasis; Levamisole; Male; Moniliformis; Morantel; Muscle Contraction; Nicotine; Parasympatholytics; Parasympathomimetics; Rats | 1987 |
In vitro cyclic nucleotide responsiveness of leukocytes and platelets in patients suffering from atopic dermatitis.
Topics: Adult; Blood Platelets; Choline; Cyclic AMP; Cyclic GMP; Dermatitis, Atopic; Epinephrine; Female; Humans; Leukocytes; Levamisole; Male; Middle Aged; Nucleotides, Cyclic | 1981 |
In vitro adsorption-desorption of phenethylamines and phenylimidazoles by a bentonite and a resin.
Topics: Adsorption; Bentonite; Choline; Hydrogen-Ion Concentration; Imidazoles; In Vitro Techniques; Ion Exchange Resins; Kinetics; Levamisole; Phenethylamines; Sodium | 1984 |
Multifocal inflammatory leukoencephalopathy: use of thallium-201 SPECT and proton MRS.
Topics: Adjuvants, Immunologic; Antimetabolites, Antineoplastic; Aspartic Acid; Axons; Biopsy; Brain; Brain Neoplasms; Choline; Colorectal Neoplasms; Diagnosis, Differential; Fluorouracil; Humans; Lactic Acid; Leukoencephalopathy, Progressive Multifocal; Levamisole; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neoplasm Metastasis; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon | 2003 |
The Ror receptor tyrosine kinase CAM-1 is required for ACR-16-mediated synaptic transmission at the C. elegans neuromuscular junction.
Topics: Acetylcholine; Analysis of Variance; Animals; Animals, Genetically Modified; Behavior, Animal; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcium; Choline; Cholinergic Antagonists; Diagnostic Imaging; Dihydro-beta-Erythroidine; Electric Stimulation; gamma-Aminobutyric Acid; Gene Expression Regulation; In Vitro Techniques; Ion Channel Gating; Levamisole; Membrane Potentials; Microscopy, Electron, Transmission; Molecular Biology; Movement; Muscles; Mutagenesis; Mutation; Neuromuscular Junction; Neurons; Nicotine; Patch-Clamp Techniques; Receptor Protein-Tyrosine Kinases; Receptor Tyrosine Kinase-like Orphan Receptors; Receptors, Nicotinic; RNA, Small Interfering; Synaptic Transmission; Synaptic Vesicles; Time Factors; Trans-Activators | 2005 |